REQUEST A DEMO
Total
USD $0.00
Search more companies

Npp Avivak OOO (Russia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Npp Avivak OOO Profile Updated: August 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Npp Avivak OOO is an enterprise in Russia, with the main office in Gorbunki. The company operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on December 23, 2002. It currently has a total number of 165 (2022) employees. In 2023, the company reported a net sales revenue increase of 27.45%. Its’ total assets recorded a growth of 23.29%. The enterprise’s net profit margin increased by 1.61% in 2023.

Headquarters
Gorbunki, 21, A
Gorbunki; Leningrad Oblast; Postal Code: 188502

Contact Details: Purchase the Npp Avivak OOO report to view the information.

Website: http://www.avivac.com

Basic Information
Total Employees:
Purchase the Npp Avivak OOO report to view the information.
Outstanding Shares:
Purchase the Npp Avivak OOO report to view the information.
Registered Capital:
Purchase the Npp Avivak OOO report to view the information.
Incorporation Date:
December 23, 2002
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
41.7%
Purchase this report to view the information.
8.3%
Subsidiaries
Rossiiskii Soyuz Proizvoditelei Veterinarnykh Lekarstvennykh Sredstv i Kormovykh Dovavok
Company Performance
Financial values in the chart are available after Npp Avivak OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
27.45%
Total operating revenue
27.45%
Operating profit (EBIT)
42.86%
Net Profit (Loss) for the Period
36.83%
Total assets
23.29%
Total equity
30.37%
Operating Profit Margin (ROS)
4.02%
Net Profit Margin
1.61%
Return on Equity (ROE)
1.36%
Debt to Equity Ratio
-5.42%
Quick Ratio
-6.97%
Cash Ratio
-4.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?